Supplementary Figure from Targeting CD73 with AB680 (Quemliclustat), a Novel and Potent Small-Molecule CD73 Inhibitor, Restores Immune Functionality and Facilitates Antitumor Immunity
Authors:
- Dana PiovesanDPDana Piovesan
- Joanne B.L. TanJTJoanne B.L. Tan
- Annette BeckerABAnnette Becker
- Jesus BanuelosJBJesus Banuelos
- Nell NarasappaNNNell Narasappa
- Daniel DiRenzoDDDaniel DiRenzo
- Kristen ZhangKZKristen Zhang
- Ada ChenACAda Chen
- Elaine GinnEGElaine Ginn
- Akshata R. UdyavarAUAkshata R. Udyavar
- Fangfang YinFYFangfang Yin
- Susan L. PaprckaSPSusan L. Paprcka
Open Access
- 3 April 2023
- other
- Published by American Association for Cancer Research (AACR)